Uniretic - 0091-3720-01 - (moexipril hydrochloride and hydrochlorothiazide)

Alphabetical Index


Drug Information of Uniretic

Product NDC: 0091-3720
Proprietary Name: Uniretic
Non Proprietary Name: moexipril hydrochloride and hydrochlorothiazide
Active Ingredient(s): 12.5; 15    mg/1; mg/1 & nbsp;   moexipril hydrochloride and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Uniretic

Product NDC: 0091-3720
Labeler Name: UCB, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020729
Marketing Category: NDA
Start Marketing Date: 20020215

Package Information of Uniretic

Package NDC: 0091-3720-01
Package Description: 100 TABLET, FILM COATED in 1 BOTTLE (0091-3720-01)

NDC Information of Uniretic

NDC Code 0091-3720-01
Proprietary Name Uniretic
Package Description 100 TABLET, FILM COATED in 1 BOTTLE (0091-3720-01)
Product NDC 0091-3720
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name moexipril hydrochloride and hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20020215
Marketing Category Name NDA
Labeler Name UCB, Inc.
Substance Name HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Strength Number 12.5; 15
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Uniretic


General Information